pCODR Monitor™ provides online access to a database of oncology drug submission records for the Pan-Canadian Oncology Drug Submission Review (pCODR). It allows you to examine the recommendation process from initial submission to recommendation decision for public drug plan reimbursement. The database includes all drugs that have gone through the process or are currently being evaluated by the pCODR.
||Easy Access via
Market Access Console